Where Will Your Drug Be in 10 Years?

We can help it get there. TD2 partners with innovative biotech and pharma companies to move their oncology medicines to the market, and faster. With translational oncology support at every moment of your drug’s journey, together we can bring cancer treatments to patients as quickly as possible.

Access Exclusive Tools

Fast-track your research with an integrated and diverse suite of preclinical tools, from more than 300 immuno-oncology models to provide strong experimental support for your strategy to bioanalytical and ADME support services.

Fill Enrollment Faster

Find trial-ready patients, even for rare diseases, with a real-time searchable database of millions of cancer patients in community oncology practices.

Get FDA Approval

From pre-IND evaluations through filing and maintenance support, we’ll help you along the path to approval and beyond—including regulatory strategy, pre-IND meetings, IND submission paperwork and everything in between.

What’s New?

How can we help you?

If you’re looking for an expert team to guide your trial with efficiency in mind, we can help. Reach out to Tessa Bivens (tbivens@td2inc.com) to get started today!